WO1998001099A3 - Method of treating retinal ischemia and glaucoma - Google Patents

Method of treating retinal ischemia and glaucoma Download PDF

Info

Publication number
WO1998001099A3
WO1998001099A3 PCT/US1997/011789 US9711789W WO9801099A3 WO 1998001099 A3 WO1998001099 A3 WO 1998001099A3 US 9711789 W US9711789 W US 9711789W WO 9801099 A3 WO9801099 A3 WO 9801099A3
Authority
WO
WIPO (PCT)
Prior art keywords
glaucoma
retinal ischemia
treating retinal
retinal
ischemia
Prior art date
Application number
PCT/US1997/011789
Other languages
French (fr)
Other versions
WO1998001099A2 (en
Inventor
E Charles Pesterfield Jr
Original Assignee
E C Pesterfield Assoc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by E C Pesterfield Assoc Inc filed Critical E C Pesterfield Assoc Inc
Priority to AU44088/97A priority Critical patent/AU4408897A/en
Publication of WO1998001099A2 publication Critical patent/WO1998001099A2/en
Publication of WO1998001099A3 publication Critical patent/WO1998001099A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone

Abstract

A method of treating ocular conditions such as retinal ischemia, retinal vasculopathy, and glaucoma in mammals by administering an effective amount of optically pure eutomers of one or more adrenergic beta-2 agonists or biologically acceptable salts or esters thereof.
PCT/US1997/011789 1996-07-05 1997-07-03 Method of treating retinal ischemia and glaucoma WO1998001099A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU44088/97A AU4408897A (en) 1996-07-05 1997-07-03 Method of treating retinal ischemia and glaucoma, using optically pure r- or rr- isomers of adrenergic beta-2 agonists

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2189996P 1996-07-05 1996-07-05
US2190296P 1996-07-05 1996-07-05
US60/021,899 1996-07-05
US60/021,902 1996-07-05

Publications (2)

Publication Number Publication Date
WO1998001099A2 WO1998001099A2 (en) 1998-01-15
WO1998001099A3 true WO1998001099A3 (en) 1998-03-19

Family

ID=26695224

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/011789 WO1998001099A2 (en) 1996-07-05 1997-07-03 Method of treating retinal ischemia and glaucoma

Country Status (2)

Country Link
AU (1) AU4408897A (en)
WO (1) WO1998001099A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2323749A1 (en) * 1998-03-06 1999-09-10 William E. Sponsel Composition and method for treating macular disorders
WO2001041756A2 (en) * 1999-12-02 2001-06-14 University Of South Florida Method and composition for treatment of ischemic neuronal reperfusion injury
CA2660707C (en) 2006-08-10 2014-07-08 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Preparation of (r,r)-fenoterol and (r,r)- or (r,s)-fenoterol analogues and their use in treating congestive heart failure
EP2544676B1 (en) 2010-03-10 2018-09-19 The United States of America, as represented by The Secretary, Department of Health and Human Services The use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3885047A (en) * 1972-06-16 1975-05-20 Mead Johnson & Co Ocular hypotensive process employing dextrorotatory phenethanolamines

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3885047A (en) * 1972-06-16 1975-05-20 Mead Johnson & Co Ocular hypotensive process employing dextrorotatory phenethanolamines

Also Published As

Publication number Publication date
WO1998001099A2 (en) 1998-01-15
AU4408897A (en) 1998-02-02

Similar Documents

Publication Publication Date Title
AU1387088A (en) Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocularpressure
HK1015691A1 (en) Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia.
WO1997018815A3 (en) The use of adenosine uptake inhibitors for treating retinal or optic nerve head damage
CA2198245A1 (en) Methods and means for drug administration
AU7610696A (en) Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
WO1997028827A1 (en) Ophthalmic composition with regulated viscosity
AU695322B2 (en) Liposome eye drops
ATE225658T1 (en) METHOD FOR LOWERING INTRACULAR PRESSURE IN THE EYE OF MAMMALS USING POTASSIUM CHANNEL BLOCKERS
AU8170891A (en) Composition for eye drops
CA2295061A1 (en) Storage-stable ophthalmic compositions comprising diclofenac and ofloxacin
AU5446299A (en) Medicinal compositions for treating eye diseases
CA2254116A1 (en) Method and composition for the treatment of lipid and glucose metabolism disorders
EP0366279A3 (en) Ocular hypotensive agents
AU7266991A (en) 3-arylcarbonyl-1-aminoalkyl-1h-indole-containing antiglaucoma compositions
CA2254682A1 (en) Method of treating eye infections with azithromycin
WO1998021182A3 (en) Use of cis-δ4 analogs of prostaglandins as ocular hypotensives
CA2180846A1 (en) Method of treating disorders of the eye
WO1998001099A3 (en) Method of treating retinal ischemia and glaucoma
WO1998021181A3 (en) 15-fluoro prostaglandins as ocular hypotensives
BR9307099A (en) Eye drops formulation process for preparing eye drops formulation and treatment process for ocular hypertension and glaucoma
AU687906B2 (en) Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
AU609807B2 (en) A composition for the topical treatment of glaucoma or ocular hypertension
EP1000619A3 (en) Method for treating glaucoma
MXPA03005922A (en) Method for treating glaucoma ib.
AU3581695A (en) Method and means for prevention and treatment of secondary cataract

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP NO NZ

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: CA

Ref country code: JP

Ref document number: 98505307

Format of ref document f/p: F

122 Ep: pct application non-entry in european phase